Yahoo
NYSE - Delayed Quote USD

ResMed Inc. (RMD)

228.35 -0.84 (-0.37%)
At close: September 4 at 4:00:02 PM EDT
228.35 0.00 (0.00%)
After hours: September 4 at 7:30:07 PM EDT
Trade ResMed on Coinbase
Chart Range Bar
Loading chart for RMD

What's happening with RMD?

14m ago
Powered by Yahoo Scout

ResMed has faced challenges following its recent Q4 earnings report, which showed revenue growth but a conservative fiscal 2027 outlook. The company is navigating issues related to a device recall and competitive pressures while continuing to invest in its digital health solutions.

Powered by Yahoo Scout
  • Previous Close 229.19
  • Open 225.91
  • Bid 227.64 x 40000
  • Ask 227.77 x 10000
  • Day's Range 225.16 - 228.49
  • 52 Week Range 180.27 - 284.87
  • Volume 837,607
  • Avg. Volume 1,484,866
  • Market Cap (intraday) 32.94B
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) 21.87
  • EPS (TTM) 10.44
  • Earnings Date (est.) Oct 29, 2026
  • Forward Dividend & Yield 2.64 (1.16%)
  • Ex-Dividend Date Aug 20, 2026
  • 1y Target Est 246.12

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

www.resmed.com

11,370

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RMD
4.42%
S&P 500 (^GSPC)
12.75%

1-Year Return

RMD
15.72%
S&P 500 (^GSPC)
18.71%

3-Year Return

RMD
47.74%
S&P 500 (^GSPC)
70.93%

5-Year Return

RMD
19.22%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.43B
Earnings 398.73M
Profit Margin 27.86%

Q1

FY26

Q2

FY26

Q3

FY26

0
500M
1B
26.5%
27.0%
27.5%

Analyst Insights

View More

Analyst Price Targets

175.00 Low
246.12 Average
228.35 Current
320.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/31/2026
Analyst Keybanc
Rating Action Maintains
Rating Overweight
Price Action Raises
Price Target 255 -> 267

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.95%

  • Return on Assets (ttm)

    14.00%

  • Return on Equity (ttm)

    24.27%

  • Revenue (ttm)

    5.65B

  • Net Income Avi to Common (ttm)

    1.52B

  • Diluted EPS (ttm)

    10.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.47B

  • Total Debt/Equity (mrq)

    12.54%

  • Levered Free Cash Flow (ttm)

    939.25M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: